# Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment

> **NCT00691808** · PHASE2 · COMPLETED · sponsor: **Lexicon Pharmaceuticals** · enrollment: 103 (actual)

## Conditions studied

- Age-Related Memory Disorders

## Interventions

- **DRUG:** LX6171 High Dose
- **DRUG:** LX6171 Low Dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00691808
- **Lead sponsor:** Lexicon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2010-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691808, "Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00691808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*